Formula1.jpg (Formula1)
Midazolam Injection
Product Images NDC 0404-9801
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 0404-9801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Formula2.jpg (Formula2)
This text is not enough to generate a useful description.*
Formula3.jpg (Formula3)
This is a graph showing the pH dependence of the open-ring form in water. It indicates the percentage of open-ring form at different pH levels. The percentage appears to decrease as the pH increases from 2.5 to 5.5.*
Image1.jpg (Image1)
This text provides information on the percentage of local effects and headache as side effects associated with an intramuscular injection. The common local effects include pain(3.7%), induration(0.5%), redness(0.5%), and muscle stiffness(0.3%). Headache is reported at a rate of 1.3%.*
Image2.jpg (Image2)
This list provides the percentage of different side effects associated with a specific treatment or medication, such as hiccoughs, nausea, vomiting, coughing, oversedation, headache, drowsiness, tenderness, pain during injection, redness, induration, and phlebitis at the IV site.*
Image3.jpg (Image3)
The text provides an assessment tool called OBSERVER'S ASSESSMENT OF ALERTNESS/SEDATION (OAA/S), which includes categories evaluating responsiveness, speech, facial expression, and eyes. The tool assigns scores ranging from 0 to 5 based on the individual's level of alertness or sedation. This tool can be used to assess a person's state of consciousness by observing their reactions to stimuli such as name calling, speech, facial expressions, and eye movements.*
Image4.jpg (Image4)
This text provides data on the frequency of an observer's assessment of alertness/sedation composite scores in a study involving children receiving intravenous midazolam for sedation during procedures. The data is presented based on different age ranges, with the number of participants (n) and the distribution of scores in categories ranging from deep sleep to alertness. The study includes age ranges of 1-2 years, >2-5 years, >5-12 years, and >12-17 years.*
Label1.jpg (Label1)
The provided text seems to be a label for Midazolam injection, with the concentration of 50 mg per 10 mL. The medication is stored at a specific temperature range and contains benzyl alcohol. It is indicated to be kept out of children's reach and is for prescription use only. The manufacturer is listed as "Hikma". Additionally, some manufacturing and packaging information is included, such as lot numbers, expiration dates, and the company involved in packaging (Henry Schein, Inc.).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
